{"as_of":"2026-08-07T15:32:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:a46f41eea4e6396a4abb5d70bc4a77660eab39268a41dff5f0479fe8d18491dc","coverage":[{"denominator":37,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":37,"source":"paper_references, paper_reference_links","source_observed_at":"2026-07-11T10:39:07.826269Z","state":"measured"},{"denominator":37,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":37,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-07T06:34:17.273281+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2607.04976/citation-record","integrity":"/paper/2607.04976/integrity","json":"/paper/2607.04976/citation-record.json","paper":"/paper/2607.04976"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:1c33433cb978e51fd65b4b702e05ff02afa5ce101577f52985ad4975c4db104d","observation_id":"16a8eede-555a-4f3f-9575-cd65b6790fb2","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"non-informative","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:40a78eed1c959e786f3c450658b23bb33297f4687e962d65b34bf7dc32b66034","observation_id":"25aad82b-e497-40e0-9d02-7a0aa0197723","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":null,"venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:3f7548bde01d398148570521020865e6d57712d6184753b9c2fa6677cf40becb","observation_id":"96d60168-991f-48bb-ad93-2271ddbba3c5","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"The testing of statistical hypotheses in relation to probabilities a priori","venue":null,"work_id":null,"year":1933},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:9ba23a62750708b041ee7dcd1b339688d38704a7490e573ddd3264c6647589d7","observation_id":"055ed040-c04f-4c6f-8f83-8294493fc6aa","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","venue":null,"work_id":null,"year":1995},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:5d734dcde77704cccd50b847b7282d2c701b77d3559e082ebee5f6ceabf3eefa","observation_id":"aabd6567-9fa8-4a24-bcc6-22dd297e036e","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A Sharper Bonferroni Procedure for Multiple Tests of Significance","venue":null,"work_id":null,"year":1988},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:34f711120dc58886fcbfbb25751651284294a6f2a95329fd966fb57117525ccc","observation_id":"361a0793-3110-458a-82a6-4fad81539daf","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1002/9780470316672","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"Multiple Comparison Procedures","venue":"Wiley series in probability and statistics","work_id":"72ec6e4e-079d-45f2-b1ae-c951cf939cae","year":1987},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:7bc03853030caf6b201436f0c82f1f99b43cb4df77d7d8839129f29b83c5a32b","observation_id":"d3e43d5f-4d81-48da-b037-46c78bd70bac","resolution":{"observed_at":"2026-07-11T10:47:57.873262Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-07-11T22:49:31.220165+00:00","source":"crossref_status_cache"},{"observed_at":"2026-07-11T22:49:31.220165+00:00","source":"openalex_status_cache"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A Simple Sequentially Rejective Multiple Test Procedure","venue":null,"work_id":null,"year":1979},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:d3fcd6084acf88e4fda5b5e778cf376533ace46c74dfa8a6096e74939129ad6c","observation_id":"cf3d931f-7f87-4031-81ed-e759c1b96be7","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"The problem of multiple comparisons","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:511de963106076b82cab621edf8be980fa666064b83900f977a54c2f6c127a86","observation_id":"6e1ff43e-e4a2-4617-b0f9-8c74b900a98f","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Multiple testing in clinical trials","venue":null,"work_id":null,"year":1991},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:ebaebc38c7091898f5cf054260f1b550f0deb7f57bdcb26785b203bdf8ba10d9","observation_id":"9aac600e-23ed-4788-b9e8-f8ff424a387a","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Repeated Significance Tests on Accumulating Data","venue":null,"work_id":null,"year":1969},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:0178492ac16f8ef107d60d3fb7f7f47316d715034ffb50d3bda8f8900bb76682","observation_id":"3b0ee430-a1f3-4813-88f0-c196c267f9ae","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A case for bayesianism in clinical trials","venue":null,"work_id":null,"year":1993},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:adcbe38c9ea30817ea1513f4045a3661f4a37bd4be75f30bdb4ddb48afdea7dd","observation_id":"b4de8fb1-bbce-464a-8c3e-369659a21279","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Bayesian clinical trials","venue":null,"work_id":null,"year":2006},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:993d055dacecf27824d43cbd8e53fb1eceeb2cefee6816f4a5af7263211d2b12","observation_id":"cfb37049-952e-4407-a469-38232953b4aa","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus","venue":null,"work_id":null,"year":2013},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:2738c0c49434cd21544c10af152d1111d094ad39da6ffd3fb023aa0a7adc77c3","observation_id":"025436a7-c41f-40dc-a5da-3cc8106d5450","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A practical guide to adopting Bayesian analyses in clinical research","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:967543d06a5b735e9f923ff588b6d307efd0babca3cf3f769eaab1b9619b6eea","observation_id":"77e2755b-a04a-40fd-a753-644acb90a470","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:3bd33d3200ff7271d98ca29e42c3fbf5462052494e2d7af4253218f117fe76a0","observation_id":"aad3bd19-dbb4-4d3d-b605-6dac7d236608","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Characteristics, design, and statistical methods in platform trials: a systematic review","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:ec7b020528d5352d2a83d9f5bd44d5f859181ab1ab26c03bcd2d8317255fe74f","observation_id":"527f67ca-cb69-4fda-9d9a-31dd1de117e1","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Application of Bayesian approaches in drug development: starting a virtuous cycle","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:424b074a2b56f049c37b5a067b32066cbde10bd03beae20fe7bf7f26fccc7142","observation_id":"cb6d4ef1-0e72-4ca7-84da-15cf4a5aa49b","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Bayesian analysis in confirmatory clinical trials: A narrative review and discussion of current practice","venue":null,"work_id":null,"year":2026},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:f110352f68e9f45ce2c846678da593188bb32c63d3d5d4a17ae0e3c14c9276d5","observation_id":"2b7c0315-823d-4798-8c84-99a752239a45","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Interim Analysis in Clinical Trials: The Role of the Likelihood Principle","venue":null,"work_id":null,"year":1987},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:41742edb575cc4ca19c398b72bebd9219bd9fe951f672edfd0e653119eb0f4c5","observation_id":"81575bba-2171-4b0d-8369-195f0f6a022d","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A Bayesian group sequential design for a multiple arm randomized clinical trial","venue":null,"work_id":null,"year":1995},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:bf808da9e2019105a898f0fd441fff3e6a677b673780cb0478c0cb92d6a31693","observation_id":"aa6a3618-2a5e-4ba8-a7a4-05fd7d5d47a4","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Do we need to adjust for interim analyses in a Bayesian adaptive trial design? BMC Med Res Methodol 2020; 20: 150","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:eb83837877d4a225639e31401bb667b221f05306de4b3803d6b4ce3362da34d2","observation_id":"013bf42a-4705-46e7-b4bd-7dcf5eef690e","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Comparison of Bayesian with group sequential methods for monitoring clinical trials","venue":null,"work_id":null,"year":1989},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:d61e576026ecf6b1d0e8d0e56bd6db2f1f28aa0b76e9631d4ceece25feafaf4a","observation_id":"51be4148-4268-4362-822f-98997ab883fb","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Problems of multiplicity in clinical trials","venue":null,"work_id":null,"year":1994},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:acbc3f5595b9c07d0966cffb3c969bf958368aaf4ad23cebc33963b13d3c2b6d","observation_id":"15d06497-1f02-49d9-8d87-8977af56b83d","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Comparison of Bayesian and frequentist group-sequential clinical trial designs","venue":null,"work_id":null,"year":2020},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:8f28aa6cde3166eaabe9d00059bfc85c98feb064d59ff8c500d19e9bb0805c41","observation_id":"4a006fcb-1c0c-4aec-b187-e8ff8d8545a8","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Bayesian Analytical Methods in Cardiovascular Clinical Trials: Why, When, and How","venue":null,"work_id":null,"year":2025},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:74a8db41330468e0587f5084f4f9cbd39541942507624f37e480b1e118188c68","observation_id":"3d1e172b-d233-40d6-9b4a-9229d4b741ae","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":null,"venue":null,"work_id":null,"year":2026},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:17abbc073b0484feb12aaf624d060543213d95446c9c3e0f5ba9514739f0c87c","observation_id":"efa824a4-aac5-44e1-91f0-961f5318afda","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"The Positive False Discovery Rate: A Bayesian Interpretation and the q-Value","venue":null,"work_id":null,"year":2003},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:de8dab5e2ef27292f948211f1062279d01f0cfac3ad78feb5dfdaf179efad324","observation_id":"97e30ac7-c1bd-4bcc-954d-a5a10dfdeefa","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"R: A Language and Environment for Statistical Computing","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:7bcfda569e68809dac94dc1697a3999e6df5107b4a7c123098c2f79c17f35834","observation_id":"d000bc92-9f5a-4124-aaf3-c8fa6d439745","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Group sequential methods in the design and analysis of clinical trials","venue":null,"work_id":null,"year":1977},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:eda34ab987e94f464254644084da01baefbf97bb0427957b3c7d2575e4d3439a","observation_id":"ae84e415-7017-4501-911f-2e52d9d2e78d","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"The choice of sequential boundaries based on the concept of power spending","venue":null,"work_id":null,"year":1991},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:814e24f70fcd8b9021b98f15d26ddea9053f88ed2f750a6b61011a0935ff8989","observation_id":"c094c5a4-e3af-4e29-b2e5-47574e5c6111","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A Multiple Testing Procedure for Clinical Trials","venue":null,"work_id":null,"year":1979},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:1a0e09500655586c6aa98bc87a3520708ab6b925800d3751b67ccd10d90313a0","observation_id":"301f5244-89a4-4f2c-81a5-2d568cc65c2a","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"Interim analysis: The alpha spending function approach","venue":null,"work_id":null,"year":1994},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:023dc8f110e326b19b06931fd5d0df178bcd675c4c42713ca3463f406ca780bb","observation_id":"c9697e83-92c4-47a5-9150-81ec90dcafe4","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.31234/osf.io/x4azm","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"Group Sequential Designs: A Tutorial","venue":null,"work_id":"82b3626f-2ed5-4a84-893a-a3957bff2206","year":2021},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:7f7ca7f51a09681c93a20ca634bbb60be24809d4cfa130e595a1f6bd6f53756c","observation_id":"71a6dd3f-b947-4265-ab78-f3b0ce203a84","resolution":{"observed_at":"2026-07-11T10:47:57.869116Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-07-11T22:49:31.454754+00:00","source":"crossref_status_cache"},{"observed_at":"2026-07-11T22:49:31.454754+00:00","source":"openalex_status_cache"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.1214/18-ba1109","metadata_source":"openalex","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T02:28:24.338817Z","title":"Control of Type I Error Rates in Bayesian Sequential Designs","venue":"Bayesian Analysis","work_id":"79a34f47-01b4-4484-ac63-ebd4d4a6933e","year":2019},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:bc2ba9badbff33f3097296df7e65d22f4719d5b9521c45f5bcb581a0756370aa","observation_id":"8814acb1-bf55-4ba8-8c1c-3ccb343541e9","resolution":{"observed_at":"2026-07-11T10:47:57.864664Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-07-11T22:49:31.702166+00:00","source":"crossref_status_cache"},{"observed_at":"2026-07-11T22:49:31.702166+00:00","source":"openalex_status_cache"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"A Bayesian sequential design using alpha spending function to control type I error","venue":null,"work_id":null,"year":2017},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:ecfb48859b29e59dc445292b79be8335d54803d9957c2a846477b0e3faf54df7","observation_id":"e9710074-647e-4320-9298-12efc7eecd00","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-07-11T10:39:07.826269Z","title":"analysis.idx","venue":null,"work_id":null,"year":2019},"citing_paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-07-11T10:39:07.826269Z"},"links":{"citing_paper":"/paper/2607.04976"},"observation_digest":"sha256:6af70bb75a1c76008053808b7ea4887ca9860f617439e0e644ca7e39f5722d66","observation_id":"ec7bc9e3-19cc-4921-97c1-47fea221d2cc","resolution":{"observed_at":"2026-07-11T10:39:07.826269Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}}],"paper":{"arxiv_id":"2607.04976","last_updated":"2026-07-06T12:10:34Z","latest_version":1,"primary_category":"stat.AP","snapshot_observed_at":"2026-08-02T21:45:29.267996Z","submitted_at":"2026-07-06T12:10:34Z","title":"Impact of interim analyses on Bayesian and frequentist operating characteristics of Bayesian clinical trials"},"reference_resolution":{"displayed":37,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":34,"verified_exact":3,"verified_fuzzy":0},"total_outbound_references":37},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"thesis":"As of 7 August 2026, this Paper Citation Record lists 37 of 37 outbound references and 0 inbound Pith citation observations for arXiv:2607.04976."}